Sanofi US announced today that the iBGStar Blood Glucose Monitoring System, consisting of the iBGStar blood glucose meter and iBGStar Diabetes Manager App, is commercially available in the U.S. iBGStar is the first Food and Drug Administration (FDA) cleared blood glucose meter that directly connects to the iPhone® and iPod touch, offering accurate blood glucose monitoring that seamlessly integrates into the lives of people with diabetes. iBGStar is available for purchase at Apple Retail Stores and all Walgreens stores nationwide, online at Apple.com, Walgreens.com and through Diabetic Care Services.
“Many people with diabetes today rely both on their iPhone or iPod touch and blood glucose monitors as important parts of their daily lives,” said Naina Sinha, MD, an in-patient diabetes attending physician and assistant professor of medicine at a leading academic medical center and university in New York City, in the press release. “By combining these two essential tools, iBGStar makes it possible to provide blood glucose tracking, monitoring and reporting together in a new way.”
When iBGStar is directly connected to an iPhone or iPod touch and used with the iBGStar Diabetes Manager App, blood glucose results are presented on the Multi-Touch display quickly after monitoring.
iBGStar can also be used independently to measure blood glucose levels; results can be synchronized later to an iPhone® or iPod touch. iBGStar and BGStar Blood Glucose Test Strips, which are used with iBGStar, are available at all Walgreens stores nationwide and online at Walgreens.com and through Diabetic Care Services. These test strips may be covered under certain health insurance plans so individuals should check directly with their provider.
The iBGStar Diabetes Manager App has a range of features and multiple views for analyzing glucose patterns on-the-go. Visual graphs and statistics can help people record and track their readings, carbohydrate intake, insulin doses (if taking insulin) and more. Color-coded scorecards show individual monitoring results for easy identification of high or low blood glucose levels. A ‘share’ function allows specific data to be sent via e-mail to caregivers and/or healthcare teams.
“Sanofi is pleased to launch iBGStar, which expands our diabetes portfolio as we pursue comprehensive disease management offerings and further illustrates our commitment to developing innovative solutions that help improve the lives of people with diabetes,” commented Dennis Urbaniak, Vice President, Head of U.S. Diabetes, Sanofi US, in the press release. “The iBGStar Blood Glucose Monitoring System will help people living with diabetes check their blood sugar and communicate with their healthcare teams, using mobile technologies that have become central to so many people’s lives.”
In March 2010, Sanofi and AgaMatrix signed an agreement for the development, supply and commercialization of Blood Glucose Monitoring solutions. iBGStar is a result of this agreement.
iBGStar®received the Good Design Award in 2011 for outstanding product design in the medical category from the Chicago Athenaeum of Architecture and Design and the European Centre for Architecture Art Design and Urban Studies. Additionally, iBGStar received the red dot design award in 2011 for outstanding product design in the life science and medicine category. The red dot design award is one of the most renowned international design competitions, with almost 14,000 entries from 68 countries in 2010 alone. Winners are considered to be the best design in the industry worldwide.